ArticleslgStudy

chemistry

TAS-108

TAS-108 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand TAS-108 rather than just read about it. In short: TAS-108, also known as SR-16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has shown signs of treating and preventing breast cancer, even in patients where tamoxifen has failed.

TAS-108 — main illustration
TAS-108 — illustration

Key takeaways

  • TAS-108 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect TAS-108 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of TAS-108 from memory before moving on to harder problems.

Reference excerpt

TAS-108, also known as SR-16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has shown signs of treating and preventing breast cancer, even in patients where tamoxifen has failed.

Development Masato Tanabe's team at SRI has focused on the development of steroid hormones. A compound discovered in a previous SRI contract from the National Institutes of Health showed potential – it acted like "anti-estrogen" in the breasts and uterus but like normal estrogen elsewhere in the body, and was more "tissue-selective". A contract was proposed to Taiho Pharmaceutical in July 1996, and within six years and slightly under $3 million (an unusually short amount of time), two new drugs were discovered and tested on people (particularly people for which tamoxifen has failed): SR-16234 and SR-16287. The first of those, SR-16234, also inhibited the growth of blood vessels angiogenesis and accelerated the death of cancer cells apoptosis and thus was particularly well suited to be an anti-cancer drug. As of August 2010, the drug had been through five Phase I and two Phase II studies, and Phase III studies are being planned.

See also Cytestrol acetate Fulvestrant ICI-164384

References

External links SR-16234 (TAS-108) - AdisInsight TS 108 at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

Illustrations

TAS-108 illustration

Worked examples

Example 1 — a first encounter with TAS-108

Start with the simplest possible case. Write down what TAS-108 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to TAS-108 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about TAS-108 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of TAS-108

In research
TAS-108 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses TAS-108 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
TAS-108 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antiestrogens, Diethylamino compounds, Estranes, so understanding it makes those chapters shorter.
In everyday life
Look for TAS-108 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study TAS-108 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what TAS-108 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain TAS-108 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is TAS-108 in simple terms?

TAS-108, also known as SR-16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has shown signs of treating and preventing breast cancer, even in patients where tamoxifen has failed.

Why does TAS-108 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study TAS-108?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on TAS-108.

Tags

  • Antiestrogens
  • Diethylamino compounds
  • Estranes
  • Experimental cancer drugs
  • SRI International
  • Taiho Pharmaceutical

Keep exploring